Sun Pharma exposed to some headline risk amid US tariff move, but with limited earnings impact We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
India’s generic drugs safe as Trump targets branded pharma imports: Experts We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
US President Donald Trump’s Friday announcement of a 100% tariff on pharmaceutical products may not affect Indian pharma exports as the measure currently targets only “patented and branded products,” while India predominantly ships generic drugs to the US, experts said. “Because the 100% tariff is targeted at branded/patented drugs, most Indian generic exports would not…
WASHINGTON — President Trump on Thursday evening threatened pharmaceutical companies with a 100% tariff unless they build manufacturing plants in the U.S. The tariff would begin on Oct. 1 and could affect all “branded or patented” drugs, the president said in a social media post. Companies could avoid it by building manufacturing facilities in the…
Megan Molteni reports on discoveries from the frontiers of genomic medicine, neuroscience, and reproductive tech. She joined STAT in 2021 after covering health and science at WIRED. You can reach Megan on Signal at mmolteni.13. It’s been 70 years since Philadelphia-based McNeil Laboratories introduced the first pure acetaminophen product to American consumers: Elixir Tylenol, a…
WASHINGTON — President Trump’s anti-vaccine comments on Monday signal health secretary Robert F. Kennedy Jr.’s growing influence — and raise new questions about how far the pair may go to upend vaccine policy. Standing with Kennedy beside him at the White House, Trump called the childhood vaccine schedule a “disgrace” and railed against the practice…
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. I’ve started the week confused. Were ACIP’s recommendations modest or a worrisome break from established vaccine policy? Will the government shut down? Does the…
WASHINGTON — President Trump on Monday suggested an overhaul to how children get vaccinated after claiming, without evidence, that many vaccines are unsafe as currently given. The president said he has talked with health secretary Robert F. Kennedy Jr. about his proposed changes. While Trump has occasionally expressed skepticism of some vaccines, the president’s comments…
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. In a highly unusual move, the Food and Drug Administration re-approved a drug on Monday that stopped being sold more than 25 years ago, part of a push from the Trump administration to identify the causes…
WASHINGTON — Congress is again discussing the Trump administration’s plan to force drug companies to lower their U.S. prices, at least behind the scenes. Congressional staffers and health policy experts from major think tanks held a closed-door meeting to discuss policy options that would peg U.S. prices for drugs to what other countries pay, called…